All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
NSCLC Oncology 2022
Pearls Discussio
AWC
2022
WEC
2022
Cemiplimab
NSCLC
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
NSCLC Oncology 2022
Pearls Discussio
AWC
2022
WEC
2022
Cemiplimab
NSCLC
Platinum-Based Chemo Doublets: Backbone for NSCLC Treatment | CancerGRACE
Nov 12, 2018
cancergrace.org
Dr. West on FDA Approval of Frontline Alectinib in ALK NSCLC | OncLive
Nov 7, 2017
onclive.com
Testing for ALK Rearrangements in Advanced NSCLC | OncLive
Feb 19, 2025
onclive.com
ASCO 2024 Updates: Novel Approaches in NSCLC Therapy | OncLive
Jul 22, 2024
onclive.com
Treatment Options for NSCLC With Low PD-L1
May 2, 2019
medscape.com
The Treatment Landscape For Advanced EGFR-Mutant NSCLC | Oncology Nursing News
10 months ago
oncnursingnews.com
WCLC 2024 Insights: Management of Brain Metastases in Oncogene-Driven NSCLC - Timing, Sequency, and Modality of RT
146 views
Sep 18, 2024
vumedi.com
4:59
Incorporation of guidelines-concordant immunotherapy in the perioperative setting of NSCLC
Nov 26, 2024
reachmd.com
1:52
Just ahead of #ASCO20 we spoke with medical oncologist Howard (Jack) West, M.D., about the role social media will play in facilitating discussions on the latest research in oncology during this virtual meeting. | City of Hope
589.6K views
May 29, 2020
Facebook
City of Hope
Insights from global key opinion leaders on optimizing patient care in NSCLC
Nov 26, 2024
reachmd.com
Emerging and practice-changing directions in NSCLC within the perioperative and locally advanced settings
Nov 26, 2024
reachmd.com
Choosing Between Atezolizumab and Pembrolizumab in Lung Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Jul 2, 2018
targetedonc.com
4:48
Pemetrexed for Advanced NSCLC
4.2K views
Jul 17, 2019
YouTube
OncLive
8:48
Non-Small Cell Lung Cancer – An Introduction
19.9K views
Jul 3, 2018
YouTube
Cancer.Net
4:22
Nivolumab in Non-Small Cell Lung Cancer
7.9K views
Nov 22, 2014
YouTube
OncLive
0:49
Dr. West Talks About Anticipated Future Clinical Trials
87 views
Aug 1, 2011
YouTube
OncLive
5:48
Oncogene-addicted NSCLC
2.4K views
8 months ago
YouTube
COR2ED The Heart of Medical Education
7:47
The Future of NSCLC Management
92 views
Apr 22, 2015
YouTube
OncLive
4:09
Using Immunotherapy Beyond Progression in NSCLC
91 views
Jul 23, 2018
YouTube
OncLive
5:00
Implications for Pembrolizumab in NSCLC
3.2K views
Jun 27, 2018
YouTube
OncLive
38:51
ASCO 2022: Highlights and analysis
477 views
Sep 7, 2022
YouTube
ecancer
7:15
Treating Limited and Advanced Stage SCLC - 2022 Program: LCVL
55 views
Jun 13, 2023
YouTube
Global Resource for Advancing Cancer Education
5:45
Locally Advanced NSCLC: Chemoradiotherapy Versus Surgery
168 views
Jun 25, 2018
YouTube
Targeted Oncology
2:32
Stage III NSCLC Progression Treatment Strategy
147 views
Jul 5, 2020
YouTube
OncLive
27:51
Prostate Cancer Conference Highlights from ASCO 2022
3.4K views
Jun 24, 2022
YouTube
Dana-Farber Cancer Institute
8:20
Immunotherapy Before Surgery in NSCLC
43 views
Sep 14, 2022
YouTube
Global Resource for Advancing Cancer Education
1:40
Jack West, MD: Clinical Criteria for Dose Reduction
30 views
Oct 22, 2015
YouTube
Targeted Oncology
6:13
CheckMate-227: Testing Ipilimumab/Nivolumab in NSCLC
432 views
Jul 23, 2018
YouTube
OncLive
28:55
Immunotherapy in lung cancer with Dr. Jack West, Part 2
274 views
Nov 14, 2019
YouTube
MDedge: news and insights for busy physicians
4:54
Small Cell Lung Cancer: Histology and Staging - 2022 Program: LCVL
322 views
Jun 13, 2023
YouTube
Global Resource for Advancing Cancer Education
See more
More like this
Feedback